Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Q3 2021 vs. Q2 2021
How the institutions holding Revolution Medicines, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 130 | 114 | −16 |
| Shares | 70.4M | 72.3M | +1.94M (+2.8%) |
| Value | $2.23B | $1.99B | −$244.2M (−10.9%) |
New holders (11)
Institutions that held Revolution Medicines, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commodore Capital LP | 226,228 | $6.22M | 1.64% |
| MPM Oncology Impact Management LP | 150,000 | $4.13M | 0.64% |
| SG Americas Securities, LLC | 46,205 | $1.27M | 0.01% |
| Dimensional Fund Advisors LP | 27,400 | $754.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 16,990 | $468.0K | 0.06% |
| Belvedere Trading LLC | 9,792 | $274.0K | 0.07% |
| Teacher Retirement System of Texas | 7,557 | $208.0K | 0.00% |
| Point72 Hong Kong Ltd | 4,162 | $114.0K | 0.01% |
| Royal Bank of Canada | 1,755 | $48.0K | 0.00% |
| Signaturefd, LLC | 26 | $1.00K | 0.00% |
| Bell Investment Advisors, Inc | 16 | $0 | 0.00% |
Sold out (27)
Institutions that held Revolution Medicines, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.